N-1H-benzimidazol-2-yl-2-chloroacetamide, 95.0%, 250mg

(R)-Ethyl 2-((tert-butoxycarbonyl)amino)-3-hydroxypropanoate, 95.0%, 100g

5-Methoxy-N-(piperidin-4-yl)pyridin-2-amine trihydrochloride, 1g

ROTI®Pol TaqS, 500 µl, 5 x 100 µl

MPEP, 97%, 1g

2-Bromo-1,1-difluorocyclopentane, 97%, 250mg

7-BROMO-1,5-NAPHTHYRIDIN-4-AMINE, 95.0%, 250mg

5-NITRO-3-(PIPERAZIN-1-YLMETHYL)-1H-INDOLE, 95.0%, 250mg

2-Bromo-4-(bromomethyl) pyridine, 95.0%, 100mg

7-Methoxy-1,2,3,4-tetrahydroisoquinoline, 95.0%, 100mg

4,6-Dimethyl-2h,3h-[1,2]thiazolo[5,4-b]pyridin-3-one, 95+%, 1g

2,6-Dimethylquinolin-4-amine hydrochloride, 250mg

tert-Butyl (2-(2-acetylhydrazinyl)-2-oxoethyl)carbamate, 95%, 10g